Skip to main content

Table 2 Subgroup analysis results of NLR and ovarian cancer survival (OS and PFS)

From: Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review

Subgroup Analysis Univariate analysis Heterogeneity P1 value Multivariate analysis Heterogeneity P2 value
NO. ES (95% CI) NO. ES (95% CI)
NLR for OS 8 2.21 (1.95-2.52) 0.000 8 1.34 (1.16-1.54) 0.004
Subgroup 1: cut-off
 >  200 5 2.26 (1.97-2.59) 0.000 5 1.32 (1.14-1.52) 0.060
 ≤ 200 3 1.82 (1.20-2.76) 0.012 3 1.78 (0.95-3.32) 0.004
Supgroup 2: sample size
 >  200 3 2.24 (1.92-2.61) 0.000 3 1.35 (1.12-1.63) 0.142
 ≤ 200 5 2.16 (1.70-2.74) 0.033 5 1.32 (1.07-1.64) 0.002
 NLR for PFS 5 2.22 (1.92-2.57) 0.000   1.36 (1.17-1.57) 0.024
Subgroup 1: cut-off
 >  200 3 3.17 (2.63-3.83) 0.000   1.36 (1.17-1.58) 0.114
 ≤ 200 2 1.28 (1.01-1.62) 0.012   1.34 (0.74-2.44) 0.009
Supgroup 2: sample size
 >  200 1 5.09 (3.89-6.68) /   1.33 (1.14-1.55) 0.098
 ≤ 200 4 1.58 (1.32-1.88) 0.004   1.62 (1.02-2.59) 0.020